The efficacy and safety of zavegepant nasal inhalation versus oral calcitonin-gene related peptide receptor antagonists in the acute treatment of migraine: a systematic review and network meta-analysis of the literature
Abstract Background The latest randomized controlled trial (RCT) revealed that zavegepant, a new nasal inhalation calcitonin gene-related peptide (CGRP) receptor antagonist, has a clear efficacy in the acute treatment of migraine. However, whether the efficacy of this new nasal inhalation drug is be...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
BMC
2025-03-01
|
| Schriftenreihe: | The Journal of Headache and Pain |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1186/s10194-025-01984-7 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|